Nike's Turnaround: If the Shoe Fits, Buy It!

Nike (NKE) exceeded FQ1 expectations, reporting nearly 1% revenue growth and adjusted EPS of $0.49, almost double consensus, largely driven by its core brand and a strategic pivot to wholesale channels despite a gross margin contraction. While forecasting a Q2 revenue decline and a "lumpy recovery," management maintains an optimistic long-term outlook for growth and shareholder returns. This performance, coupled with improving analyst sentiment and aggressive institutional accumulation, suggests a market bottom for NKE, with potential for the stock to reach $90 by year-end.

Analysis

Nike's FQ1 results indicate its turnaround strategy is gaining initial traction, with revenue growth of nearly 1.0% and adjusted EPS of $0.49 significantly outperforming consensus expectations by 650 basis points and nearly 100%, respectively. This performance is primarily driven by a strategic pivot back to the wholesale channel, which grew 7% and offset a 4% decline in direct sales and a sharp 27% contraction in the Converse brand. However, this shift has come at the cost of profitability, contributing to a gross margin contraction of over 300 basis points. Despite management's cautious guidance for a Q2 revenue decline and a 'lumpy recovery,' market sentiment is turning positive. Analyst ratings are firming with a 'Moderate Buy' consensus and a rising price target of $81.57, while strong institutional accumulation, with buying outpacing selling by a 2-to-1 ratio, supports the technical view that the stock price may be bottoming out.

Key Decisions for Investors

• Investors with a higher risk tolerance could consider the stock's current level a potential entry point, given the strong FQ1 earnings beat and supportive institutional flows that suggest a turnaround is underway.
• Monitor upcoming quarterly reports for evidence of gross margin stabilization, as sustained margin pressure from the wholesale channel shift could impede the path to long-term profitable growth and challenge the bullish thesis.
• Given management's forecast for a near-term revenue decline, investors should weigh the positive analyst sentiment and technical bottoming signals against the company's own cautious outlook for a 'lumpy recovery'.